All In Biotech

Drug Trial Radar · NCT02317705

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

A Phase 2, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

Last checked: Nov 19, 2026Latest source record: Jun 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

48

Actual

Start

Dec 2014

Primary completion

Nov 2015

Study completion Nov 2015

Sponsor

Lead sponsor
On Target Laboratories, LLCIndustry
Sponsor type
Industry
Collaborators
SynteractHCR
First posted
Dec 16, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being done to: * test the safety of OTL38 * see if OTL38 helps light up the cancer when viewed with the special camera system * test the safety of the special camera system for use along with OTL38 during surgery

Conditions

  • Ovarian Cancer

Interventions

  • OTL38Drug

  • Near infrared camera imaging systemDevice

    Near infrared camera imaging system

  • LaparotomyProcedure

    primary surgical cytoreduction, interval debulking, or recurrent ovarian cancer surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity of OTL38 in Detecting Folate Receptor-alpha Positive Ovarian Cancer During Surgery.Time frame: Day of Surgery (Day 1)
  2. Positive Predictive Value (PPV) of OTL38 in Detecting Folate Receptor-alpha Positive Ovarian Cancer During Surgery.Time frame: Day of Surgery (Day 1)

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • University of CA at Irvine Chao Cancer Center

    Orange, California

  • Moffitt Cancer Center

    Tampa, Florida

  • Mayo Clinic-Rochester

    Rochester, Minnesota

  • University of Pennsylvania

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.